Business Context and Reporting Period
Company: Alterity Therapeutics Limited (a development stage enterprise)
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: September 2025
Date of Filing: September 23, 2025
Principal Executive Office: Level 14, 350 Collins Street, Melbourne, Victoria 3000, Australia
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This Form 6-K serves as a notification of corporate governance events rather than a financial results report.
Material Changes and Corporate Events
- Exhibit 99.1: Submission of the date for the Annual General Meeting (AGM) and the closing date for director nominations.
- Registration Statements: This report is incorporated by reference into Registration Statements on Form S-8 (Files No. 333-251073, 333-248980, 333-228671) and Form F-3 (Files No. 333-274816, 333-251647, 333-231417, 333-250076).
Guidance, Outlook, and Risks
The filing text does not provide specific guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to procedural notifications regarding the AGM and regulatory incorporation.
Investor Verification Checklist
- Verify the specific date of the Annual General Meeting (AGM) and the deadline for director nominations in the attached Exhibit 99.1.
- Confirm the status of the referenced Registration Statements (Form S-8 and Form F-3) for potential equity issuance.
- Review the company's most recent Form 20-F or quarterly reports for actual financial performance data, as this filing contains none.